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In this issue of Cell Metabolism, Espenshade and colleagues (Hughes et al., 2007) show that the
hemoprotein Dap1/PGRMC1 forms a stable complex with several members of the cytochrome P450
superfamily of enzymes and positively regulates their activities. This action indicates an important
role for Dap1/PGRMC1 in P450-catalyzed reactions, some of which are involved in the metabolism
of sterols and pharmaceutical compounds.The term ‘‘cytochrome P450’’ was first
coined in 1962 by Omura and Sato to
describe a membrane-bound, heme-
containing protein characterized by
a 450 nm spectral peak when com-
plexed with carbon monoxide (Omura
and Sato, 1962). This unique spectral
absorption was later exploited by
Estabrook and colleagues (1963) to
demonstrate a role for cytochrome
P450 in C21 hydroxylation of 17-
hydroxyprogesterone. These seminal
observations set in motion an explo-
sion of biochemical, molecular, and
genetic studies that underlie our cur-
rent understanding of the cytochrome
P450 (CYP) superfamily of enzymes.
The more than 5000 P450s are dis-
persed among many organisms, rang-
ing from animals and plants to fungi
and bacteria, suggesting a great diver-
sity in their physiologic roles. Indeed,
P450 enzymes act on many endoge-
nous substrates, including fatty acids,
sterols, steroids, and bile acids. More-
over, P450s metabolize various foreign
compounds such as drugs, xenobi-
otics, and plant products; in many
cases, their actions lead to detoxifica-
tion and elimination of these chemi-
cals. The importance of cytochrome
P450 enzymes is further highlighted
by the association of mutations in sev-
eral CYP genes with clinically relevant
diseases (Nebert and Russell, 2002).
A recent study by Espenshade and
colleagues (Hughes et al., 2007)
provides new insights into regulation
of P450 activity that will likely have
profound implications for metabolism
of endogenous and exogenous P450
substrates.
The human CYP superfamily
comprises 57 genes arranged into 18families and subfamilies according to
amino acid identity. Fourteen of these
enzymes are involved in the metabo-
lism of sterols (Figure 1) (Nebert and
Russell, 2002). Six P450 enzymes
(CYP11A1, 17A1, 21A2, 19A1, 11B1, and
11B2) participate in steroidogenesis,
and seven (CYP7A1, 27A1, 46A1,
7B1, 39A1, 8B1, and 3A4) are involved
in the synthesis of bile acids, the
major route for disposal of cholesterol
in mammals. The CYP51A1 gene en-
codes lanosterol 14a-demethylase,
which catalyzes removal of the 14a-
methyl group from the cholesterol syn-
thesis intermediate lanosterol through
three consecutive oxidation reactions.
CYP51A1 is highly conserved, being
found in plants, fungi, protozoa, and
bacteria, which has led to the specula-
tion that the enzyme represents an an-
cestor of all eukaryotic P450 enzymes.
In mammalian cells, cholesterol syn-
thesis is subjected to stringent feed-
back control by membrane-bound
transcription factors called sterol
regulatory element-binding proteins
(SREBPs) (Goldstein et al., 2006). In
cholesterol-deprived cells, SREBPs
are transported from the ER to the
Golgi, where they encounter proteases
that release active SREBPs from
membranes. These products migrate
to the nucleus and enhance transcrip-
tion of genes for cholesterol synthetic
enzymes such as CYP51A1. SCAP is
a polytopic membrane protein that
binds SREBPs in the ER and facilitates
their translocation to the Golgi. Cho-
lesterol directly binds to SCAP, trig-
gering a conformational change that
prevents incorporation of the protein
and its bound SREBP into ER-derived
transport vesicles otherwise destinedCell Metabolismfor the Golgi. Since cholesterol-bound
SCAP no longer exits the ER, SREBPs
are not cleaved and remain tethered
to membranes; expression of target
genes falls, and cholesterol synthesis
declines.
Previous work by Espenshade and
colleagues (Hughes et al., 2005) estab-
lished an unexpected link between
oxygen sensing and sterol synthesis
in the fission yeast Schizosaccharo-
myces pombe. S. pombe expresses
homologs of mammalian SREBP and
SCAP designated Sre1 and Scp1, re-
spectively. Like mammalian SREBPs,
Sre1 is subjected to Scp1-mediated
cleavage upon sterol depletion; how-
ever, target genes of Sre1 differ from
those of mammalian SREBPs. Sre1-
responsive genes do not include those
for enzymes involved in early reactions
of sterol synthesis (such as HMG-CoA
synthase and reductase), but rather
genes encoding enzymes such as
Erg11/CYP51A1 and Erg5/CYP61A1,
which catalyze late oxygen-dependent
steps in synthesis of ergosterol (the
cholesterol equivalent in yeast). Inter-
estingly, Erg11/CYP51A1 and Erg5/
CYP61A1 are the only P450 enzymes
present in S. pombe. Other Sre1-
responsive genes encode enzymes
that catalyze oxygen-requiring reac-
tions in heme, sphingolipid, and ubi-
quinone synthesis (Todd et al., 2006).
The spectrum of genes regulated by
Sre1 is consistent with the observation
that oxygen deprivation stimulates
Sre1 cleavage and the requirement of
Sre1 and Scp1 for anaerobic growth.
Additional target genes have
emerged that suggest a key role for
Sre1 in P450 function. These include
cytochrome b5 and b5 reductase,5, February 2007 ª2007 Elsevier Inc. 81
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PreviewsFigure 1. Cytochrome P450 Enzymes Involved in the Metabolism of Sterols in Mammalian Cells
The cytochrome P450 enzymes that catalyze the various steps in metabolism of sterols are indicated in red. At least 20 enzymes are required to
synthesize cholesterol from acetyl-CoA; in mammalian cells, CYP51A1 is the only P450 enzyme that participates in cholesterol synthesis. Primary
bile acids refer to cholic acid, chenodeoxycholic acid, and at least ten other derivatives. Steroid hormones produced from pregnenolone include
dehydroepiandrosterone, androstenedione, testosterone, cortisol, and aldosterone.which donate electrons from NADPH
to microsomal P450s, and the S.
pombe homolog of a mammalian pro-
tein termed progesterone membrane
receptor component 1, or PGRMC1
(Falkenstein et al., 1996). Human
PGRMC1 is a 22 kDa protein with an
N-terminal membrane-spanning seg-
ment and a C-terminal cytochrome
b5-like domain that binds heme. Two
observations suggest that PGRMC1
modulates activity of P450 enzymes.
First, activity of CYP21A2 is enhanced
in cells upon overexpression of
PGRMC1 (Min et al., 2005). Second,
the Saccharomyces cerevisiae ortho-
log of PGRMC1 (Dap1) is required for
normal activity of Erg11/CYP51A1
and ergosterol synthesis (Mallory
et al., 2005). A direct role for Dap1
and PGRMC1 in P450 function is pro-
vided by the current Espenshade study
(Hughes et al., 2007). Their experi-
ments show that Dap1 binds heme and
positively regulates Erg11/CYP51A182 Cell Metabolism 5, February 2007 ª20and Erg5/CYP61A1. This function ap-
pears to be conserved, as indicated
by RNAi studies that reveal that
knockdown of mammalian PGRMC1
in cultured cells reduces CYP51A1 ac-
tivity, leading to toxic accumulation of
the enzyme’s substrate lanosterol. Re-
markably, coimmunoprecipitation ex-
periments demonstrate that PGRMC1
binds to CYP51A1 and three other
members of the P450 superfamily,
CYP3A4, CYP7A1, and CYP21A2.
Until now, the only known P450-
binding proteins were NADPH cyto-
chrome P450 oxidoreductase and
cytochrome b5, which deliver elec-
trons to P450 enzymes; however,
these interactions are transient. More-
over, oxidoreductase and cytochrome
b5 are only present in catalytic
amounts. The Espenshade group
(Hughes et al., 2007) found that
Dap1/PGRMC1 forms a stable, stoi-
chiometric complex with four different
P450s, which suggests that this hemo-07 Elsevier Inc.protein performs an important function
in P450-catalyzed reactions. Although
it remains to be determined whether all
P450 enzymes bind PGRMC1, its
presence in plants, flies, and worms
suggests that the protein will modulate
many family members.
Another important implication of the
Espenshade study (Hughes et al.,
2007) relates to the role of PGRMC1
in regulation of CYP51A1. PGRMC1
has been identified as a binding part-
ner for Insig1 (Suchanek et al., 2005),
an ER membrane protein that plays
a pivotal role in mediating sterol
regulation of SCAP-SREBP and
HMG-CoA reductase, the rate-limiting
enzyme of cholesterol synthesis
(Goldstein et al., 2006). It is tempting
to speculate that Insig1, through an
association with PGRMC1, also mod-
ulates CYP51A1 activity, thereby con-
trolling metabolism of lanosterol. This
speculation is especially intriguing
considering that lanosterol stimulates
Cell Metabolism
Previewsbinding of Insig1 to HMG-CoA reduc-
tase, causing ubiquitination and
degradation of the enzyme, which in
turn decreases cholesterol synthesis
(Goldstein et al., 2006).
The Espenshade study (Hughes
et al., 2007) opens new avenues of
investigation into the regulation of
P450 enzymatic activity. For example,
a close homolog of PGRMC1, desig-
nated PGRMC2, has been identified
in humans, mice, rats, chickens, frogs,
and fish (Mourot et al., 2006). Does
PGRMC2 modulate the same group
of P450s as PGRMC1, or a distinct
group? What is the precise mecha-
nism and structural basis by which
PGRMC1 (and possibly PGRMC2)
modulates activity of P450 enzymes?
Do accessory proteins that link
PGRMCs with their P450 targets
exist? What regulates expression of
PGRMC1 and PGRMC2? Are they
responsive to oxygen deprivation in
mammals? What is the significanceFly Foie Gras: Mo
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Lipids provide an essential source
periods of food deprivation. A re
in regulating lipid metabolism for
similarities to mammalian hepato
Complex organisms have evolved a
series of buffering systems to ensure
that their tissues have a dependable
supply of energy and metabolites
through alternating periods of food
availability and starvation. Lipids are
important energy carriers and, as
such, play key roles in reallocating re-
sources throughout the body during
periods of food deprivation. In mam-
mals, complex regulatory systems
act to coordinate lipid metabolism
with energy demands, involving physi-of Insig1/PGRMC1 binding? S. pombe
has an Insig1 homolog, which is desig-
nated Ins1 (Hughes et al., 2005). Does
Ins1 bind S. pombe Dap1, and is it
involved in Dap1-mediated regulation
of CYP51A1? Turnover rates of P450
enzymes in vitro are notoriously low.
Is this inefficiency caused by a disrup-
tion of complexes by the detergents
that are used to solubilize the latter
proteins prior to determination of
enzyme activity? Answers to these
questions hold promise for new, excit-
ing, and unexpected insights into the
regulation of P450 activity.
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